Reference number : 236-2016-2017-Q2-00128, amendment number : , agreement type : G, recipient legal name : Walsh, Michael W, recipient country : CA, recipient province : ON, recipient city : Hamilton, recipient postal code : L8N 3Z5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 2652816.0, agreement start date : 2016-07-01, agreement end date : 2022-06-30, description english : Aldosterone antagonism and enhanced Clearance for Health Improvement EValuation in End-stage renal disease (ACHIEVE) Trial, description french : Aldosterone antagonism and enhanced Clearance for Health Improvement EValuation in End-stage renal disease (ACHIEVE) Trial, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2016-17 to 2022-23), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2016-17 à 2022-23), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada